LPCN
Lipocine Inc.stockNASDAQ
lipocine inc., a specialty pharmaceutical company, develops and commercializes pharmaceutical products. the company develops drugs based on hydroance, a drug delivery technology. it primarily focuses on developing oral versions of several hormones for use in men and women health. the company's lipid-based technology platform offers non-invasive delivery solutions for small polar organics and macromolecules. it also offers custom drugs for pharmaceutical/biotechnology companies. lipocine inc. was founded in 1997 and is headquartered in salt lake city, utah.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 1.59 | 2026-11-11 | -4.40% | 4.559 |
| 1M | 1.53 | 2026-10-19 | -0.65% | 0.685 |
| 3M | 2.04 | 2026-08-18 | -25.49% | 0.749 |
| 6M | 2.21 | 2026-05-18 | -31.22% | 0.998 |
| 1Y | 3.38 | 2025-11-18 | -55.03% | 1.325 |
| 2Y | 4.72 | 2024-11-18 | -67.80% | — |
| 5Y | 18.53 | 2021-11-18 | -91.80% | 0.788 |
Lipocine Inc. (NASDAQ:LPCN) stock price today is $1.52, and today's volume is 63,091. LPCN is down 5.000% today. The 30 day average volume is 3.87M. LPCN market cap is $16.83M with 11.07M shares outstanding.